ArticleScientific reports2025
Tannic acid modified horizontal platelet-rich fibrin membrane with improved mechanical and biological properties for tissue regeneration : Author full names.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Use of Platelet-Rich Fibrin and Platelet-Rich Plasma as Delivery Systems for Natural Compounds: A Systematic Review.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Horizontal platelet-rich fibrin (H-PRF), containing bioactive cytokines, cells, and a three-dimensional fibrin scaffold, has been widely applied in periodontal and peri-implant tissue regeneration. Nevertheless, its suboptimal mechanical strength and rapid degradation limit its clinical application. There is an urgent need for strategies that enhance its durability without compromising biocompatibility. This study introduces tannic acid (TA) as a biocompatible crosslinking agent to improve the mechanical performance and degradation resistance of H-PRF membranes. H-PRF membranes treated with 10 mg/mL TA for 5 min exhibited optimal mechanical properties, as confirmed by scanning electron microscopy and tensile strength testing. Compared with conventional H-PRF, TA-PRF demonstrated prolonged degradation in plasmin digestion assays and enhanced antibacterial activity against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), including greater resistance to bacterial penetration in vitro. These findings indicate that TA modification provides a straightforward, cost-effective, and biocompatible approach for producing H-PRF membranes with superior mechanical strength, extended longevity, and enhanced antibacterial properties, which could serve as promising alternatives or adjuncts to conventional barrier membranes in regenerative dentistry and related fields, and may pave the way for broader clinical applications in soft and hard tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.